4Goossens GH. The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance [J]. Physiol Behav,2008,94(2):206-218.
5Canoy D. Distribution of body fat and risk of coronary heart disease in men and women [J]. Curr Opin Cardiol, 2008,23(6):591-598.
6de Koning L, Merchant AT, Pogue J, et al.Waist circumference and waist-to-hip ratio as predictors of cardiovascular events: meta-regression analysis of prospective studies[J]. Eur Heart J, 28(7):850-856.
7Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling [J]. Diabetes Care,2004,27 (6):1487- 1495.
8Bao Y, Lu J, Wang C, et al. Optimal waist circumference cutoffs for abdominal obesity in Chinese[J]. Atherosclerosis,2008,201 (2):378-384.
9Cullen P. Evidence that triglycerides are an independent coronary heart disease risk factor[J]. Am J Cardiol,2000, 86(9):943-949.
10Pradhan AD, Ridker PM. Do atherosclerosis and type 2 diabetes share a common inflammatory basis? [J]. Eur Heart J,2002,23(11):831-834.
3Li CJ,Yu Q,Yu P,et al.Changes in liraglutide-induced body composition are related to modifications in plasma cardiac natriuretic peptides levels in obese type 2 diabetic patients[J],Cardiovasc Diabetol,2014,13(1):1-11.
4Chinen I,Shimabukuro M,Yamakawa K,et al.Vascular lipotoxicity : endothelial dysfunction via fa tty-acid-induced reactive Oxygen species overproduction in obese Zucker diabetic fatty rats[J].Endocrinology,2007,148(1):160-165.
